Aurinia Pharmaceuticals Inc - Common Shares (AUPH) SEC filings
AUPH SEC filings moved a median of -0.20% by the close. AUPH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AUPH overview →
47 measured AUPH SEC filing events.
Where these AUPH SEC filings landedvs 47 measured AUPH SEC filing reactions
| Middle 50% of AUPH SEC filing reactions | -2.24% to +2.00% |
|---|---|
| Median reaction (to close) | -0.20% |
| Measured reactions | 47 |
Point-in-time · zero look-ahead
Half of the 47 AUPH SEC filing events with a measured close landed between -2.24% and +2.00%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aurinia Pharmaceuticals For: Aug 19 | SEC filing · Form 8-K | -0.24% | -1.41% | |
| Form 8-K Aurinia Pharmaceuticals For: Aug 19 | SEC filing · Form 8-K | -1.24% | -0.36% | |
| Form 8-K Aurinia Pharmaceuticals For: Aug 19 | SEC filing · Form 8-K | +3.07% | +4.04% | |
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -1.17% | +1.25% | |
| Form 8-K Aurinia Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | -1.17% | +1.25% | |
| Form 8-K Aurinia Pharmaceuticals For: Jun 03 | SEC filing · Form 8-K | +1.40% | -3.77% | |
| Form 8-K Aurinia Pharmaceuticals For: May 08 | SEC filing · Form 8-K | +2.11% | +3.83% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.25% | -6.54% | |
| Form 8-K Aurinia Pharmaceuticals For: May 07 | SEC filing · Form 8-K | -0.25% | -6.54% | |
| Form DEF 14A Aurinia Pharmaceuticals For: Jun 03 | SEC filing · Form DEF | +0.13% | +3.08% | |
| Form 8-K Aurinia Pharmaceuticals For: Mar 30 | SEC filing · Form 8-K | +2.69% | +2.50% | |
| Form 8-K Aurinia Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | +0.85% | +1.11% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.98% | -5.93% | |
| Form 8-K Aurinia Pharmaceuticals For: Feb 26 | SEC filing · Form 8-K | -0.98% | -5.93% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +12.89% | +5.70% | |
| Form 8-K Aurinia Pharmaceuticals For: Nov 04 | SEC filing · Form 8-K | +12.89% | +5.70% | |
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.69% | -2.17% | |
| Form 8-K Aurinia Pharmaceuticals For: Jul 31 | SEC filing · Form 8-K | +0.69% | -2.17% | |
| Form 8-K Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 8-K | +0.00% | -2.31% | |
| Form S-8 Aurinia Pharmaceuticals | SEC filing · Form S-8 | +0.55% | -0.86% | |
| Form 8-K Aurinia Pharmaceuticals For: May 15 | SEC filing · Form 8-K | +0.12% | +0.99% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.31% | -0.37% | |
| Form 8-K Aurinia Pharmaceuticals For: May 12 | SEC filing · Form 8-K | -0.31% | -0.37% | |
| Form DEFA14A Aurinia Pharmaceuticals | SEC filing · Form DEFA14A | +0.69% | +2.74% | |
| Form DEFA14A Aurinia Pharmaceuticals | SEC filing · Form DEFA14A | -0.75% | +1.50% | |
| Form DEF 14A Aurinia Pharmaceuticals For: May 15 | SEC filing · Form DEF | -0.39% | -0.78% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -13.65% | -2.33% | |
| Form 8-K Aurinia Pharmaceuticals For: Feb 27 | SEC filing · Form 8-K | -13.65% | -2.33% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +2.81% | +6.38% | |
| Form 8-K Aurinia Pharmaceuticals For: Nov 07 | SEC filing · Form 8-K | +2.81% | +6.38% | |
| Form 8-K Aurinia Pharmaceuticals For: Sep 09 | SEC filing · Form 8-K | -0.29% | +2.63% | |
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.78% | -2.77% | |
| Form 8-K Aurinia Pharmaceuticals For: Aug 01 | SEC filing · Form 8-K | -0.78% | -2.77% | |
| Form 8-K Aurinia Pharmaceuticals For: Jun 14 | SEC filing · Form 8-K | -0.71% | -1.25% | |
| Form DEFA14A Aurinia Pharmaceuticals | SEC filing · Form DEFA14A | -0.37% | -1.50% | |
| Form ARS Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -0.59% | +0.78% | |
| Form DEF 14A Aurinia Pharmaceuticals For: Jun 14 | SEC filing · Form DEF | -0.59% | +0.78% | |
| Form DEFA14A Aurinia Pharmaceuticals | SEC filing · Form DEFA14A | -0.59% | +0.78% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -3.35% | -8.98% | |
| Form 8-K Aurinia Pharmaceuticals For: May 02 | SEC filing · Form 8-K | -3.35% | -8.98% | |
| Form 10-K/A Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.49% | -0.20% | |
| Form 8-K Aurinia Pharmaceuticals For: Feb 27 | SEC filing · Form 8-K | -1.40% | +0.87% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.08% | +1.35% | |
| Form 8-K Aurinia Pharmaceuticals For: Feb 15 | SEC filing · Form 8-K | +0.08% | +1.35% | |
| Form 8-K Aurinia Pharmaceuticals For: Jan 05 | SEC filing · Form 8-K | -1.80% | -0.47% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +2.78% | +4.23% | |
| Form 8-K Aurinia Pharmaceuticals For: Nov 02 | SEC filing · Form 8-K | +2.78% | +4.23% |
Keep exploring
More AUPH: earnings → · analyst actions → · AUPH overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TETRALOGIC PHARMS CORP (TLOG) | 226 | +0.20% | 52% |
| Y-mAbs Therapeutics, Inc. (YMAB) | 226 | -0.20% | 39% |
| Cel-Sci Corporation (CVM) | 224 | -0.54% | 37% |
| OraSure Technologies, Inc. (OSUR) | 224 | -0.17% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.